+143.3%
MRNA vs RGEN
+39.8%
+103.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | RGEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.1% | -1.3% | -1.2% |
| 7D | -10.1% | -4.6% | -5.5% | -5.5% |
| 30D | +126.7% | +1.2% | +125.6% | +130.6% |
| 3M | +184.1% | +26.8% | +157.3% | +168.5% |
| 6M | +143.3% | +29.1% | +114.2% | +127.7% |
| All | +143.3% | +39.8% | +103.5% | +127.7% |
Cumulative growth
Daily Returns
Daily percentage return beside RGEN.
Daily Out/Under-Performance
Portfolio return minus RGEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RGEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded RGEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling